In November 2021, Repetitive Transcranial Magnetic Stimulation therapy was added to the Medicare Benefits Schedule for eligible patients with diagnosed medication-resistant major depressive disorder.
The treatment is particularly useful for patients who don’t respond to drug therapies and are at risk of self-harm.
